US Oncology Vice President of Diversity Salary | Comparably
US Oncology operates a network of integrated community-based oncology practices that provides cancer care services in the United States. read more
EMPLOYEE
PARTICIPANTS
80
TOTAL
RATINGS
550

US Oncology Vice President of Diversity Salary

The average US Oncology Vice President of Diversity earns an estimated $271,967 annually. US Oncology's Vice President of Diversity compensation is $47,534 more than the US average for a Vice President of Diversity.

The HR Department at US Oncology earns $3,542 more on average than the Design Department.

Last updated 7 months ago.

$53k
$108k
$159k
$212k
$344k
$475k
$600k
$271,967
Average Compensation
$271,967
avg. base

Vice President of Diversity Salaries at US Oncology

Vice Presidents of Diversity earn $87,075 more than Directors of HR.

Director of HR
$185k*
HR Manager
$118k*
Recruiter
$104k*
* estimated salary

Compensation at US Oncology by Department

The HR Department averages $3,542 more than the Design Department, and $7,335 less than the Marketing Department

Marketing
$117,454 Avg. total comp.
+$7k
HR
$110,119 Avg. total comp.
Design
$106,577 Avg. total comp.
-$4k

Vice President of Diversity Compensation by Gender (All Companies)

The average female Vice President of Diversity at companies similar size to US Oncology reported making $278,742, while the average male Vice President of Diversity at similar sized companies reported making $252,263.

Vice President of Diversity Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Vice President of Diversity at companies similar size to US Oncology reported making $327,333, while the average Hispanic or Latino Vice President of Diversity at similar sized companies reported making $111,000.

How Vice Presidents of Diversity at US Oncology Rate Their Compensation

The majority of Vice Presidents of Diversity at US Oncology believe they're compensated fairly. 50% of Vice Presidents of Diversity at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology

×
Rate your company